TR201007109A2 - Tek birim dozaj formları. - Google Patents

Tek birim dozaj formları.

Info

Publication number
TR201007109A2
TR201007109A2 TR2010/07109A TR201007109A TR201007109A2 TR 201007109 A2 TR201007109 A2 TR 201007109A2 TR 2010/07109 A TR2010/07109 A TR 2010/07109A TR 201007109 A TR201007109 A TR 201007109A TR 201007109 A2 TR201007109 A2 TR 201007109A2
Authority
TR
Turkey
Prior art keywords
dosage forms
single unit
unit dosage
donepezil
alzheimer
Prior art date
Application number
TR2010/07109A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07109A priority Critical patent/TR201007109A2/tr
Priority to TR2011/08087A priority patent/TR201108087A2/tr
Priority to PCT/TR2011/000192 priority patent/WO2012026904A1/en
Publication of TR201007109A2 publication Critical patent/TR201007109A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)

Abstract

Mevcut buluş donepezil veya farmasötik açıdan uygun herhangi bir türevini ve ginkgo biloba özütü içeren tek birim dozaj formlarma ve bu tarz dozaj formlarının alzheimer tedavisinde kullanımına ilişkindir.
TR2010/07109A 2010-08-25 2010-08-25 Tek birim dozaj formları. TR201007109A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/07109A TR201007109A2 (tr) 2010-08-25 2010-08-25 Tek birim dozaj formları.
TR2011/08087A TR201108087A2 (tr) 2010-08-25 2011-08-12 Tek birim katı dozaj formları.
PCT/TR2011/000192 WO2012026904A1 (en) 2010-08-25 2011-08-19 A single unit dosage form on the basis of a combination comprising donepezil and ginkgo biloba extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07109A TR201007109A2 (tr) 2010-08-25 2010-08-25 Tek birim dozaj formları.

Publications (1)

Publication Number Publication Date
TR201007109A2 true TR201007109A2 (tr) 2012-03-21

Family

ID=44947168

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2010/07109A TR201007109A2 (tr) 2010-08-25 2010-08-25 Tek birim dozaj formları.
TR2011/08087A TR201108087A2 (tr) 2010-08-25 2011-08-12 Tek birim katı dozaj formları.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/08087A TR201108087A2 (tr) 2010-08-25 2011-08-12 Tek birim katı dozaj formları.

Country Status (2)

Country Link
TR (2) TR201007109A2 (tr)
WO (1) WO2012026904A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007774A1 (en) * 2012-07-02 2014-01-09 Mahmut Bilgic Water soluble formulations comprising a piperidine derivative active agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
WO2012026904A1 (en) 2012-03-01
TR201108087A2 (tr) 2012-07-23

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
TN2015000076A1 (en) Methods of treating alzheimer's disease and pharmaceutical compositions thereof
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
IL216599A (en) 4,1-Bi-Conjugated Phthalazine History, Pharmaceuticals Containing Them and Their Use in Cancer Treatment
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016002580A (es) Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas.
IN2012DN05186A (tr)
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
CL2014003607A1 (es) Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer.
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.
TR201007110A2 (tr) Sinerjik etki gösteren kombinasyonlar
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
IN2014DN09437A (tr)
TR201108087A2 (tr) Tek birim katı dozaj formları.
TR201007111A2 (tr) Sinerjik etki gösteren bileşimler.
TR201100152A2 (tr) Amlodipin içeren efervesan bileşimler.
WO2014023869A3 (es) Aplicacion terapéutica de agentes inhibidores de cd44 frente a la leucemia linfoblástica aguda (all) humana
TR200906322A2 (tr) Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
PH12019501070A1 (en) Sustained-release dosage forms of ruxolitinib
TR201204568A2 (tr) Galantamin içeren efervesan tablet.
IN2013MU01245A (tr)
IN2013MU01249A (tr)